CHERYLE BRANDT: Open Payments
NPI 1457338543 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$752 in 41 payments from 13 companies in 2025. Trend: 2023 $1,424 · 2024 $1,350 · 2025 $752
Food & beverage: $752
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $223 |
| UCB, Inc. | 3 | $70 |
| GENZYME CORPORATION | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| PFIZER INC. | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| LEO Pharma Inc. | 2 | $47 |
| Amgen Inc. | 2 | $44 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $40 |
Products named: SKYRIZI, DUPIXENT, Bimzelx, CIBINQO, ADBRY, Otezla, Sotyktu, Zoryve.
Industry payments across SD — which companies pay providers there.
